Background
In the spring of 2020, New York City was an epicenter of coronavirus disease 2019 (COVID‐19). The post‐hospitalization needs of COVID‐19 patients were not understood and no outpatient rehabilitation programs had been described.
Objective
To evaluate whether a virtual rehabilitation program would lead to improvements in strength and cardiopulmonary endurance when compared with no intervention in patients discharged home with persistent COVID‐19 symptoms.
Design
Prospective cohort study.
Setting
Academic medical center.
Patients
Between April and July 2020, 106 patients discharged home with persistent COVID‐19 symptoms were treated. Forty‐four patients performed virtual physical therapy (VPT); 25 patients performed home physical therapy (HPT); 17 patients performed independent exercise program (IE); and 20 patients did not perform therapy.
Interventions
All patients were assessed by physiatry. VPT sessions were delivered via secure Health Insurance Portability and Accountability Act compliant telehealth platform 1‐2 times/week. Patients were asked to follow up 2 weeks after initial evaluation.
Main Outcome Measures
Primary study outcome measures were the change in lower body strength, measured by the 30‐second sit‐to‐stand test; and the change in cardiopulmonary endurance, measured by the 2‐minute step test.
Results
At the time of follow‐up, 65% of patients in the VPT group and 88% of patients in the HPT group met the clinically meaningful difference for improvement in sit‐to‐stand scores, compared with 50% and 17% of those in the IE group and no‐exercise group (
P
= .056). The clinically meaningful difference for improvement in the step test was met by 74% of patients in the VPT group and 50% of patients in the HPT, IE, and no‐exercise groups (
P
= .12).
Conclusions
Virtual outpatient rehabilitation for patients recovering from COVID‐19 improved lower limb strength and cardiopulmonary endurance, and an HPT program improved lower limb strength. Virtual rehabilitation seems to be an efficacious method of treatment delivery for recovering COVID‐19 patients.